Rheumasense
1 known investors
Rheumasense develops clinical diagnostic testing for rheumatoid arthritis, combining Liquid Chromatography-Mass Spectrometry biomarker testing with machine learning to measure metabolites linked to RA disease activity. Using an at-home blood collection kit and lab testing at Mayo Clinic Laboratories, it provides physicians and patients with quantitative disease-activity data to guide treatment decisions and telemedicine support.
Investors · 1
Frequently asked questions
- What does Rheumasense do?
- Rheumasense develops clinical diagnostic testing for rheumatoid arthritis, combining Liquid Chromatography-Mass Spectrometry biomarker testing with machine learning to measure metabolites linked to RA disease activity. Using an at-home blood collection kit and lab testing at Mayo Clinic Laboratories, it provides physicians and patients with quantitative disease-activity data to guide treatment decisions and telemedicine support.
- Who are Rheumasense's investors?
- Rheumasense's investors include NLC.